Navigation Links
Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report
Date:5/23/2013

THURSDAY, May 23 (HealthDay News) -- A shortage of a critical tuberculosis drug has hampered the efforts of health departments across the United States to contain the spread of the highly infectious lung disease, federal officials report.

The drug, isoniazid (INH), was first used in 1951 and is one of four drugs considered to be the core of any first-line treatment for tuberculosis (TB). Patients must take the drugs for six to nine months, according to the U.S. Centers for Disease Control and Prevention.

However, a national survey of local health departments around the country in January found that many health departments and clinics were having trouble getting INH. According to the report, published in the May 24 issue of the CDC publication, Morbidity and Mortality Weekly Report, the shortage first became severe in November 2012 and was attributed to manufacturing and supply problems.

The January survey, conducted by the National Tuberculosis Controllers Association online, was sent to 68 jurisdictions in all 50 states, including health departments in 10 large U.S. cities.

The survey found that 79 percent of the TB programs that responded said they were having difficulty obtaining INH, 41 percent said they would run out of the drug within a month and 15 percent no longer had any of the drug left.

To deal with the shortage, 69 percent of the TB programs said they switched suppliers, 72 percent prioritized high-risk patients, 68 percent delayed treatment and 88 percent tried alternative treatments. Forty-four percent said they switched to more expensive TB drug regimens.

The CDC researchers said that while the shortage of INH is easing, many health departments still can't get supplies of the drug and have changed their treatment practices to deal with the shortage. The CDC is working with local, state and international officials, along with suppliers of INH, to alleviate the shortage.

More information

For more on tuberculosis, go to the U.S. Centers for Disease Control and Prevention.

-- HealthDay staff

SOURCE: Morbidity and Mortality Weekly Report, May 24, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Alzheimers Patients May Face Looming Shortage of Neurologists
2. The doctor wont see you now? Study: US facing a neurologist shortage
3. Cancer drug shortages mean higher costs and greater risk for patients
4. Nursing Shortage May Harm Infants in Intensive Care, Study Says
5. Hoping to Ease Shortage, FDA Fast-Tracks Generic Form of Cancer Drug
6. TB Drug Shortages Put U.S. Patients in Peril, Study Finds
7. Spot Shortages of Flu Vaccine, Tamiflu Reported, FDA Head Says
8. Cardiac Deaths May Lead to Shortage of Donor Livers
9. Shortage of Drug for Childrens Cancer May Have Upped Relapse Rates
10. Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients
11. Fentanyl Injection Shortages Reported: Severe Adverse Events as AttorneyOne Informs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report
(Date:8/5/2020)... ... August 05, 2020 , ... In its ... to unprecedented challenges. Regardless of the obstacle - shortages of tests, ventilators and ... and the cancellation or postponement of all nonessential services - providers across the ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... industry, as president of the largest veterinarian-owned purchasing Cooperative in the United States. ... various roles where she gained extensive knowledge and experience in the animal health ...
(Date:8/5/2020)... ... August 04, 2020 , ... Total ... Autism Spectrum Disorder (ASD) in Wisconsin, is delighted to announce the grand opening ... opening of their newest center, Total Spectrum now proudly serves ten different locations ...
(Date:8/3/2020)... ... August 03, 2020 , ... Evolution ... Suite360:Mental Health and Prevention program district-wide, developed to help students navigate a range ... , Florida schools and districts must provide their students with preventative lessons after ...
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate Therapeutics, Inc. ... with first-line advanced pancreatic cancer in a phase 2 study of 9-ING-41, as ... EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 beta (GSK-3ß) ...
Breaking Medicine News(10 mins):
(Date:8/3/2020)... ... , ... LaVoieHealthScience (LHS), an integrated investor and public relations consulting ... President, CEO and Founder of LHS, has been named to the PharmaVOICE 100 ... 100 has honored more than 1,500 industry executives for their contributions to the life ...
(Date:7/31/2020)... ... July 31, 2020 , ... Member Care Solutions announced a deal with American ... operators the licensing of their cloud based membership management software platform. , “We are ... Our software is the perfect match for many reasons, but AFC’s need to quickly ...
(Date:7/22/2020)... ... July 22, 2020 , ... TrialScope, the global leader ... addition of Moderna to its growing customer roster. , TrialScope customers include 16 ... disclosure management, patient engagement and study recruitment. Collectively, TrialScope customers are responsible for ...
Breaking Medicine Technology: